These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 4508128)

  • 1. The aromatic substrate binding site in subtilisin BPN' and its resemblance to chymotrypsin.
    Kraut J; Robertus JD; Birktoft JJ; Alden RA; Wilcox PE; Powers JC
    Cold Spring Harb Symp Quant Biol; 1972; 36():117-23. PubMed ID: 4508128
    [No Abstract]   [Full Text] [Related]  

  • 2. An x-ray crystallographic study of the binding of peptide chloromethyl ketone inhibitors to subtilisin BPN'.
    Robertus JD; Alden RA; Birktoft JJ; Kraut J; Powers JC; Wilcox PE
    Biochemistry; 1972 Jun; 11(13):2439-49. PubMed ID: 5040650
    [No Abstract]   [Full Text] [Related]  

  • 3. A new substrate and two inhibitors applicable for thermitase, subtilisin BPN' and alpha-chymotrypsin. Comparison of kinetic parameters with customary substrates and inhibitors.
    Brömme D; Fittkau S
    Biomed Biochim Acta; 1985; 44(7-8):1089-94. PubMed ID: 3910035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The topographical differences in the active site region of alpha-chymotrypsin, subtilisin Novo, and subtilisin Carlsberg. Mapping the aromatic binding site by inhibitors (virtual substrates).
    Bosshard HR; Berger A
    Biochemistry; 1974 Jan; 13(2):266-77. PubMed ID: 4810052
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of the active site stereochemistry and substrate conformation in -chymotrypsin and subtilisin BPN'.
    Wright CS
    J Mol Biol; 1972 Jun; 67(1):151-63. PubMed ID: 5064999
    [No Abstract]   [Full Text] [Related]  

  • 6. A comparison of the three-dimensional structures of subtilisin BPN' and subtilisin novo.
    Drenth J; Hol WG; Jansonius JN; Koekoek R
    Cold Spring Harb Symp Quant Biol; 1972; 36():107-16. PubMed ID: 4508127
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibition of subtilisin BPN' by reaction site P1 mutants of Streptomyces subtilisin inhibitor.
    Kojima S; Nishiyama Y; Kumagai I; Miura K
    J Biochem; 1991 Mar; 109(3):377-82. PubMed ID: 1908859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetic specificities of BPN' and Carlsberg subtilisins. Mapping the aromatic binding site.
    Karasaki Y; Ohno M
    J Biochem; 1978 Sep; 84(3):531-8. PubMed ID: 102640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reaction of azapeptides with chymotrypsin-like enzymes. New inhibitors and active site titrants for chymotrypsin A alpha, subtilisin BPN', subtilisin Carlsberg, and human leukocyte cathepsin G.
    Gupton BF; Carroll DL; Tuhy PM; Kam CM; Powers JC
    J Biol Chem; 1984 Apr; 259(7):4279-87. PubMed ID: 6368557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant chymotrypsin inhibitor 2: expression, kinetic analysis of inhibition with alpha-chymotrypsin and wild-type and mutant subtilisin BPN', and protein engineering to investigate inhibitory specificity and mechanism.
    Longstaff C; Campbell AF; Fersht AR
    Biochemistry; 1990 Aug; 29(31):7339-47. PubMed ID: 2207109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding, proteolytic, and crystallographic analyses of mutations at the protease-inhibitor interface of the subtilisin BPN'/chymotrypsin inhibitor 2 complex.
    Radisky ES; Kwan G; Karen Lu CJ; Koshland DE
    Biochemistry; 2004 Nov; 43(43):13648-56. PubMed ID: 15504027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incorporation of a stabilizing Ca(2+)-binding loop into subtilisin BPN'.
    Braxton S; Wells JA
    Biochemistry; 1992 Sep; 31(34):7796-801. PubMed ID: 1510966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a novel peptide inhibitor of subtilisin BPN'.
    Ishida K; Shimizu M; Wakasugi A; Matsui Y; Nakamura A; Kojima S
    FEBS Open Bio; 2022 Nov; 12(11):2057-2064. PubMed ID: 36053920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crystal structure of thermitase at 1.4 A resolution.
    Teplyakov AV; Kuranova IP; Harutyunyan EH; Vainshtein BK; Frömmel C; Höhne WE; Wilson KS
    J Mol Biol; 1990 Jul; 214(1):261-79. PubMed ID: 2196375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions of BPN' and Carlsberg subtilisins with peptides containing aromatic amino acids at the C-terminus. Specific rate enhancement due to the secondary enzyme-substrate interaction.
    Karasaki Y; Ohno M
    J Biochem; 1979 Aug; 86(2):563-7. PubMed ID: 479143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crystal structures of Streptomyces subtilisin inhibitor and its complex with subtilisin BPN'.
    Mitsui Y; Satow Y; Watanabe Y; Hirono S; Iitaka Y
    Nature; 1979 Feb; 277(5696):447-52. PubMed ID: 763329
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of secondary interaction on the enzymatic activity of subtilisin BPN': comparison with alpha-chymotrypsin, trypsin, and elastase.
    Morihara K; Oka T
    FEBS Lett; 1973 Jun; 33(1):54-6. PubMed ID: 4737331
    [No Abstract]   [Full Text] [Related]  

  • 18. A kinetic investigation of the crystallographically deduced binding subsites of bovine chymotrypsin A .
    Segal DM
    Biochemistry; 1972 Feb; 11(3):349-56. PubMed ID: 5062058
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of alpha-chymotrypsin and subtilisin BPN': size and specificity of the active site.
    Morihara K; Oka T; Tsuzuki H
    Biochem Biophys Res Commun; 1969 Apr; 35(2):210-4. PubMed ID: 4977270
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparative studies of the specificities of -chymotrypsin and subtilisin BPN'. Studies with flexible substrates.
    Pattabiraman TN; Lawson WB
    Biochem J; 1972 Feb; 126(3):645-57. PubMed ID: 5075271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.